Search research articles
Contact Us
Filters
Showing results (31-40 of 205) with videos related to
Page
of 21
Sort By:
Neuro-Degenerative Diseases
|
December 14, 2007
Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis
Bert A 't Hart, Rogier Q Hintzen, Jon D Laman
Trends in Molecular Medicine
|
December 16, 2014
Cytomegalovirus: a culprit or protector in multiple sclerosis?
Marjan Vanheusden, Piet Stinissen, Bert A 't Hart, et al.
Clinical Pharmacology and Therapeutics
|
July 28, 2017
Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery
Bert A 't Hart, Jon D Laman, Yolanda S Kap
Trends in Molecular Medicine
|
May 20, 2009
Multiple sclerosis - a response-to-damage model
Bert A 't Hart, Rogier Q Hintzen, Jon D Laman
Expert Opinion on Drug Discovery
|
March 14, 2013
The significance of non-human primates as preclinical models of human arthritic disease
Michel Vierboom, Elia Breedveld, Ivanela Kondova, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 15, 2009
Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development
Yolanda S Kap, Jon D Laman, Bert A 't Hart
Frontiers in Psychiatry
|
April 20, 2017
Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy
Peter de Haan, Hans C Klein, Bert A 't Hart
Journal of Immunology (Baltimore, Md. : 1950)
|
June 9, 2017
EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis
Elena Morandi, S Anwar Jagessar, Bert A 't Hart, et al.
Drug Discovery Today
|
June 26, 2012
The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease
Bert A 't Hart, David H Abbott, Katsuki Nakamura, et al.
Trends in Molecular Medicine
|
June 27, 2020
Bacterial Peptidoglycan as a Driver of Chronic Brain Inflammation
Jon D Laman, Bert A 't Hart, Christopher Power, et al.
Page
of 21
Search research articles
Search
Showing results (31-40 of 205) with videos related to
Sort By:
Page
of 21
Neuro-Degenerative Diseases
|
December 14, 2007
Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis
Bert A 't Hart, Rogier Q Hintzen, Jon D Laman
Trends in Molecular Medicine
|
December 16, 2014
Cytomegalovirus: a culprit or protector in multiple sclerosis?
Marjan Vanheusden, Piet Stinissen, Bert A 't Hart, et al.
Clinical Pharmacology and Therapeutics
|
July 28, 2017
Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery
Bert A 't Hart, Jon D Laman, Yolanda S Kap
Trends in Molecular Medicine
|
May 20, 2009
Multiple sclerosis - a response-to-damage model
Bert A 't Hart, Rogier Q Hintzen, Jon D Laman
Expert Opinion on Drug Discovery
|
March 14, 2013
The significance of non-human primates as preclinical models of human arthritic disease
Michel Vierboom, Elia Breedveld, Ivanela Kondova, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 15, 2009
Experimental autoimmune encephalomyelitis in the common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development
Yolanda S Kap, Jon D Laman, Bert A 't Hart
Frontiers in Psychiatry
|
April 20, 2017
Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy
Peter de Haan, Hans C Klein, Bert A 't Hart
Journal of Immunology (Baltimore, Md. : 1950)
|
June 9, 2017
EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis
Elena Morandi, S Anwar Jagessar, Bert A 't Hart, et al.
Drug Discovery Today
|
June 26, 2012
The marmoset monkey: a multi-purpose preclinical and translational model of human biology and disease
Bert A 't Hart, David H Abbott, Katsuki Nakamura, et al.
Trends in Molecular Medicine
|
June 27, 2020
Bacterial Peptidoglycan as a Driver of Chronic Brain Inflammation
Jon D Laman, Bert A 't Hart, Christopher Power, et al.
Page
of 21